ArticlePloS one2026
The post-activation performance enhancement of sub-maximal load back squat with varied range of motion and intra-set fatigue on jump height in trained males.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-activation performance enhancement (PAPE) is a strategy in sports science that improves athletic performance through preconditioning muscle activity. This study investigates the acute effects of sub-maximal load back squats with different ranges of motion (ROM) and intra-set fatigue on countermovement jump (CMJ) height.
methodsThis study employed a counterbalanced, repeated-measures experimental design to investigate the acute effects of sub-maximal load back squat with varied ROM and intra-set fatigue on CMJ height in trained males. A total of 12 resistance-trained athletes participated in a single-set protocol intervention comprising 4 conditioning activities (CAs): (i) deep squats with proximity-to-failure (SDP); (ii) deep squats to failure (SDF); (iii) half squats with proximity-to-failure (SHP); and (iv) half squats to failure (SHF). CMJ height was measured before the CAs and at 4, 8, and 12 minutes post-intervention, while mean velocity was continuously monitored during the CAs.
resultsNo significant differences were observed in initial mean velocity across conditioning activities (F = 1.10, ηp² = 0.07, p = 0.36). Final repetition mean velocity differed significantly across conditions (F = 6.67, ηp² = 0.31, p < 0.01), with lower velocities and a greater number of repetitions observed in the failure conditions compared with the proximity-to-failure conditions (p < 0.01). A significant condition × time interaction was found for CMJ height (F = 2.231, ηp² = 0.13, p = 0.02). CMJ height increased at 4 minutes post-CA in the SDP and SHP conditions (p < 0.01 and p = 0.03, respectively), while increases occurred at 8 minutes post-CA in the SDF and SHF conditions (p = 0.03 and p < 0.01, respectively). A significant between-group effect was also observed (F = 3.949, ηp² = 0.21, p = 0.01). No between-group differences were present at 4 minutes post-CA (p = 0.24), but significant differences emerged at 8 and 12 minutes post-CA (both p < 0.01).
conclusionBoth proximity-to-failure and repetitions-to-failure protocols performed at 87% 1RM effectively enhanced CMJ performance. However, peak performance occurred earlier following the proximity-to-failure protocols, and half squats elicited greater enhancement effects than deep squats. These findings suggest that 3 repetitions of the half squat at 87% 1RM may represent a time-efficient strategy for inducing PAPE when explosive performance is required shortly before competition or training.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.